Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...
Cancer patients undergoing treatment require a carefully managed diet and healthy lifestyle to support recovery, improve treatment tolerance, and enhance quality of life. Here is a...
The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...